BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11781277)

  • 1. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review.
    Dulai GS; Guha S; Kahn KL; Gornbein J; Weinstein WM
    Gastroenterology; 2002 Jan; 122(1):26-33. PubMed ID: 11781277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II).
    Ruol A; Merigliano S; Baldan N; Santi S; Petrin GF; Bonavina L; Ancona E; Peracchia A
    Dis Esophagus; 1997 Jul; 10(3):190-5. PubMed ID: 9280078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus.
    Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
    Aliment Pharmacol Ther; 2016 Oct; 44(8):775-84. PubMed ID: 27562355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.
    Tan MC; Mansour N; White DL; Sisson A; El-Serag HB; Thrift AP
    Aliment Pharmacol Ther; 2020 Jul; 52(1):20-36. PubMed ID: 32452599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
    Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
    Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma in Barrett's esophagus.
    Altorki NK; Skinner DB
    Semin Surg Oncol; 1990; 6(5):274-8. PubMed ID: 2237086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Barrett's esophagus and esophageal adenocarcinoma.
    Shaheen NJ
    Gastroenterology; 2005 May; 128(6):1554-66. PubMed ID: 15887151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.
    Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ
    Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
    Dunbar KB
    Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of adenocarcinoma among patients with Barrett's esophagus.
    Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
    N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture.
    Chung A; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; McLeod D; Fanning S; Kariyawasam V; Byth K
    Endoscopy; 2011 Dec; 43(12):1025-32. PubMed ID: 22068701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.
    Conio M; Cameron AJ; Romero Y; Branch CD; Schleck CD; Burgart LJ; Zinsmeister AR; Melton LJ; Locke GR
    Gut; 2001 Mar; 48(3):304-9. PubMed ID: 11171817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
    DE Carli DM; Araujo AF; Fagundes RB
    Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.